Application of vanillic acid in inhibiting the growth of multi-drug resistant Enterobacter cloacae
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHAANXI UNIV OF SCI & TECH
- Publication Date
- 2021-08-13
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of medicine, in particular to the application of vanillic acid in inhibiting the growth of multidrug-resistant Enterobacter cloacae. Background technique
[0002] Enterobacter cloacae is an Enterobacteriaceae bacterium that widely exists in the intestines of animals and humans, and is a common pathogenic bacteria in hospital-acquired infections (Ning Xingwang, Zhu Huibin, Kuang Min, Xie Xiaobing, Qian Chun. 107 strains of Enterobacter cloacae produced Detection of ESBLs and AmpC enzymes and analysis of drug resistance [J]. Practical Preventive Medicine, 2018, 25(05): 534-537.), can cause multi-system infections, respiratory tract infection is the most common, and can also cause sepsis, urinary tract infection infections, wound infections, and urinary tract infections. With the overuse and abuse of antibiotics, the extensive use of immunosuppressants, chemotherapy drugs, and various invasions, the clinical isolation r...